SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-008420
Filing Date
2017-05-03
Accepted
2017-05-03 17:02:40
Documents
52
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vtvt-10q_20170331.htm 10-Q 949597
2 EX-10.1 vtvt-ex101_354.htm EX-10.1 41146
3 EX-31.1 vtvt-ex311_7.htm EX-31.1 16198
4 EX-31.2 vtvt-ex312_9.htm EX-31.2 16090
5 EX-32.1 vtvt-ex321_8.htm EX-32.1 7256
6 EX-32.2 vtvt-ex322_6.htm EX-32.2 7211
7 GRAPHIC g201705030202470473810.jpg GRAPHIC 39431
  Complete submission text file 0001564590-17-008420.txt   3515267

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT vtvt-20170331.xml EX-101.INS 493296
9 XBRL TAXONOMY EXTENSION SCHEMA vtvt-20170331.xsd EX-101.SCH 38228
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtvt-20170331_cal.xml EX-101.CAL 27980
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtvt-20170331_def.xml EX-101.DEF 163518
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtvt-20170331_lab.xml EX-101.LAB 287195
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtvt-20170331_pre.xml EX-101.PRE 220115
Mailing Address 4170 MENDENHALL OAKS PKWY HIGH POINT NC 27265
Business Address 4170 MENDENHALL OAKS PKWY HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37524 | Film No.: 17810272
SIC: 2834 Pharmaceutical Preparations